Electronic Informed Consent (eConsent) Vendor Security Risk Assessment Checklist

Use this checklist to evaluate whether an eConsent platform protects subjects, satisfies 45 CFR 46.116 compliance, and meets operational, technical, and legal expectations. It emphasizes 21 CFR part 11 readiness, HIPAA privacy rules, robust identity verification protocols, electronic signature verification, eConsent audit trail integrity, and Legally Authorized Representative authentication.

Regulatory Compliance Requirements

Confirm the vendor can operationalize the regulatory foundations of informed consent while preserving data integrity and subject rights across studies and sites.

Checklist

• Map features to 45 CFR 46.116 compliance: required consent elements, understandable language, version control, re-consent triggers, and withdrawal workflows.
• Demonstrate 21 CFR part 11 controls: validated software, unique user IDs, secure electronic signatures, record protection, and time-stamped audit trails linked to each action.
• Support IRB oversight: designate consent versions by IRB approval date, restrict use of superseded versions, and provide change summaries for board review.
• Enable multi-jurisdictional configurations (e.g., state privacy rules) without code changes; document how site-level differences are enforced.
• Provide documented CSV/CSA approach, SOPs, training records, and release/change controls aligned to regulated expectations.

Evidence to Review

• Validation package (IQ/OQ/PQ or CSA artifacts) showing requirements traceability and objective evidence.
• Part 11 assessment and risk analysis covering signatures, audit trails, and record retention.
• IRB package examples: approved consent, tracked versions, and re-consent communications.

Verification and Authentication Methods

Strong identity assurance and signature integrity protect subjects and preserve legal defensibility of consent records.

Checklist

• Identity verification protocols: configurable remote proofing (e.g., government ID scan plus liveness), knowledge-based alternatives, and site-assisted fallback with documented outcomes.
• Electronic signature verification that captures printed name, date/time, signature meaning, location context, and binds the signature cryptographically to the specific consent version.
• Configurable multi-factor authentication for subjects and staff (passkeys, TOTP, push, or SMS with rate limits and step-up prompts for high-risk actions).
• Legally Authorized Representative authentication with the same or higher assurance as the subject; collect relationship, basis of authority, and attestations with supporting documentation.
• Session security: device recognition, anomaly detection, IP throttling, and automatic logout after inactivity.

Evidence to Review

• Identity proofing workflows, assurance-level mapping, and success/failure statistics.
• Sample signed consent package showing signature metadata, hash values, and verification steps.
• Access and authentication logs demonstrating MFA and step-up events.

FDA and HIPAA Security Standards

Ensure the platform can operate in FDA-regulated environments while safeguarding ePHI under HIPAA privacy rules and security safeguards.

Checklist

• HIPAA privacy rules alignment: minimum necessary access, documented permitted uses/disclosures, subject rights support (access, amendments), and breach notification procedures.
• Security safeguards: encryption in transit (TLS 1.2+ or 1.3), encryption at rest (e.g., AES-256), key management with separation of duties, and integrity controls with tamper detection.
• 21 CFR part 11 expectations: closed-system controls, audit trails that are computer-generated, and signature/record linking that prevents substitution or falsification.
• Operational controls: role-based training, periodic access reviews, time-synced servers, and validated backup/restore processes.
• Regulatory readiness: support for FDA inspections and document requests with complete, legible, and readily retrievable records.

Evidence to Review

• HIPAA risk analysis, risk management plan, and sample Business Associate Agreement terms.
• Encryption/key-management architecture diagrams and key-rotation procedures.
• Recent independent security attestations (e.g., SOC 2 Type II) and penetration test summaries.

Documentation and Record Retention

Regulatory defensibility depends on tamper-evident records, durable storage, and complete event histories across the consent lifecycle.

Checklist

• eConsent audit trail capturing draft creation, version publication, subject/LAR views, identity checks, Q&A interactions, signatures, re-consent, and withdrawals with timestamps and actor IDs.
• Immutable storage options (WORM or equivalent) with cryptographic hashing, time-stamping, and integrity verification during export or migration.
• Configurable retention schedules and legal holds aligned to sponsor, IRB, and regulatory requirements; documented destruction workflows.
• Complete export packages: human-readable PDFs plus machine-readable data, version metadata, signature certificates, and audit logs.
• Disaster recovery for records: defined RTO/RPO, tested restores, and evidence of successful recovery drills.

Evidence to Review

• Sample record set for a subject from first view to final signature and subsequent re-consent.
• Retention and destruction SOPs; proof of legal hold and export capabilities.
• Integrity reports showing hash validation before and after transfer.

User Access Controls and Privacy

Tight, role-aware access and privacy-by-design protect subjects and reduce insider and configuration risk.

Checklist

• Granular RBAC/ABAC: study/site scoping, separation of duties, least privilege, time-limited “break-glass” access, and approval workflows.
• Enterprise identity: SSO via SAML/OIDC, MFA enforcement, SCIM/JIT provisioning, and rapid deprovisioning.
• Data minimization and pseudonymization: subject-coded IDs, masked PII in exports, and configurable redaction for monitors/auditors.
• Privacy controls: transparent notices, configurable contact preferences, and documented processes for data subject requests and withdrawals.
• Technical protections: session timeouts, IP allow/deny lists, secure secret storage, and encrypted backups with key rotation.

Evidence to Review

• Access matrix, provisioning/deprovisioning logs, and periodic access review records.
• Privacy impact assessment and responses to data subject requests.
• Configuration snapshots demonstrating role scopes and masking/redaction settings.

Risk Mitigation Strategies

Assess how the vendor prevents, detects, responds to, and recovers from security events across the product lifecycle and supply chain.

Checklist

• Secure SDLC: threat modeling, code review, SAST/DAST, software composition analysis, SBOM, and environment segregation.
• Vulnerability management: scanning cadence, SLAs by severity, verified remediation, and zero-day response procedures.
• Independent testing: annual penetration tests, targeted red teaming, and a coordinated disclosure or bug bounty program.
• Monitoring and incident response: 24/7 alerting, SIEM integration, forensics readiness, RACI-defined playbooks, and tested tabletop exercises.
• Resilience: documented BCP/DR with multi-region failover, tested recovery, and communicated RTO/RPO commitments.
• Third-party oversight: subprocessor inventory, security/Business Associate Agreement (BAA)/DPA terms, ongoing assessments, and data locality controls.
• Change and configuration management: versioned infrastructure-as-code, peer-approved changes, and rollback plans.

Evidence to Review

• Recent SOC 2 Type II or ISO 27001 certificate/report mapping to in-scope services.
• Penetration test executive summary with remediation evidence.
• Incident response and DR test reports with action items closed.

Usability and Subject Interaction

Usability directly affects comprehension, enrollment, and protocol adherence. Strong UX also reduces security workarounds and data-entry errors.

Checklist

• Accessibility: WCAG 2.1 AA support, screen-reader compatibility, captions/transcripts, keyboard navigation, and high-contrast modes.
• Comprehension: plain-language summaries, multimedia explainers, tooltips, and optional knowledge checks with remediation.
• Device and connectivity: responsive mobile-first design, low-bandwidth modes, offline progress caching, and save-and-resume invitations.
• Support and escalation: in-app Q&A logging, call scheduling, and clear pathways to site staff when identity proofing fails.
• Multi-signer flows: smooth Legally Authorized Representative authentication, co-signing steps, and confirmation receipts to all parties.
• Lifecycle messaging: automated reminders for incomplete consent, protocol amendments, and re-consent with auditable delivery status.

Summary

This checklist aligns vendor evaluations with core obligations: 45 CFR 46.116 compliance for content and process, 21 CFR part 11 for trustworthy electronic records and signatures, HIPAA privacy rules for ePHI, rigorous identity verification protocols and electronic signature verification, and durable eConsent audit trail and retention. Select vendors that can prove these controls with evidence, not just claims.

FAQs

What are the key regulatory requirements for eConsent security?

You should confirm 45 CFR 46.116 compliance for informed consent content and comprehension, ensure 21 CFR part 11 controls for validated systems, secure electronic signatures, and audit trails, and verify HIPAA privacy rules for ePHI protection. Together, these frameworks require controlled access, tamper-evident records, and traceable actions that can withstand audits and inspections.

How is subject identity verified in eConsent platforms?

Vendors should offer configurable identity verification protocols such as government ID scanning with liveness detection, knowledge-based alternatives, and site-assisted fallback. Electronic signature verification must bind the signer to the specific consent version with date/time, meaning of signature, and cryptographic integrity. For pediatric or incapacitated subjects, Legally Authorized Representative authentication must meet equal or higher assurance.

What documentation must be retained for compliance?

Retain the signed consent, all versions shown to the subject, associated signature metadata, and the complete eConsent audit trail covering views, identity checks, signatures, re-consent, and withdrawals. Keep validation evidence, IRB approvals, and exportable audit logs in durable, tamper-evident storage with documented retention schedules and legal hold processes.

How do FDA regulations impact eConsent vendor security?

FDA expectations emphasize validated systems, trustworthy electronic records, and secure electronic signatures under 21 CFR part 11, alongside protections for human subjects. Practically, this means robust access controls, immutable audit trails, verified signer identity, and repeatable processes that generate complete, readily retrievable records for inspections and investigations.